Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX1 | Q9Y5S8 | 11/20 | 0.55 |
| ▸ | GAA | P10253 | 6/20 | 0.55 |
| ▸ | MAPT | P10636 | 6/20 | 0.55 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.55 |
| ▸ | BCHE | P06276 | 2/20 | 0.55 |
| ▸ | ACHE | P22303 | 2/20 | 0.55 |
| ▸ | SNCA | P37840 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.55 |
| ▸ | MAOA | P21397 | 1/20 | 0.55 |
| ▸ | CNR1 | P21554 | 1/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.55 |
| ▸ | HTR2C | P28335 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL194062 | 0.83 | NOX1 (0.61) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL31331504 | 0.83 | NOX1 (0.61) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL21101750 | 0.83 | NOX1 (0.52) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL17746931 | 0.83 | NOX1 (0.52) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL16815268 | 0.83 | NOX1 (0.52) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL906160 | 0.81 | NOX1 (0.53) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL9474044 | 0.80 | NOX1 (0.57) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL23018616 | 0.77 | L3MBTL1 (0.54) | GAAMAPTALOX15TDP1POLB | |
| SCHEMBL7220609 | 0.77 | GAA (0.41) | GAAMAPTADORA3L3MBTL1IDO1 | |
| SCHEMBL20537255 | 0.77 | NOX1 (0.44) | NOX1GAAMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-11100373-A | — | — | None | — | — | JP | disclosed |
| CN-122079798-A | Laser molecule with cascade excited state double proton transfer activity, monocrystalline material, and preparation method and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| WO-2024260416-A1 | ORGANIC COMPOUND, PREPARATION METHOD THEREFOR, AND ELECTRONIC DEVICE | TCL科技集团股份有限公司 | 2024-12-26 | — | — | WO | disclosed |
| CN-119176817-A | Organic compound, preparation method thereof and electronic device | TCL科技集团股份有限公司 | 2024-12-24 | — | — | CN | disclosed |
| EP-2585073-B1 | ANTIVIRAL COMPOUNDS | PROSETTA ANTIVIRAL INC (US) | 2016-04-27 | — | — | EP | disclosed |
| US-8809317-B2 | Antiviral compounds | PROSETTA ANTIVIRAL INC. (US) | 2014-08-19 | — | — | US | disclosed |
| US-8785434-B2 | Antiviral compounds | PROSETTA ANTIVIRAL INC. (US) | 2014-07-22 | — | — | US | disclosed |
| EP-2585073-A1 | ANTIVIRAL COMPOUNDS | Prostetta Antiviral Inc. (US) | 2013-05-01 | — | — | EP | disclosed |
| CN-102958525-A | Antiviral compounds | PROSTETTA ANTIVIRAL INC | 2013-03-06 | — | — | CN | disclosed |
| US-20120302556-A1 | Antiviral Compounds | PROSETTA ANTIVIRAL INC. (US) | 2012-11-29 | — | — | US | disclosed |
| US-6489336-B2 | PHENOTHIAZINE, ACRIDAN, ACRIDONE OXIME, ACRIDONE HYDRAZONE, OR DIBENZODIAZEPINE DERIVATIVES; TYROSINE KINASE INHIBITORS; TREATING ALLERGIC DISEASES | EISAI CO., LTD. (JP) | 2002-12-03 | — | — | US | disclosed |
| US-20020103189-A1 | Nitrogen-containing tricyclic compounds and drugs containing the same | EISAI CO., LTD. | 2002-08-01 | — | — | US | disclosed |
| US-6333322-B1 | FOR THERAPY OF ASTHMA, ALLERGIC RHINITIS, ATOPIC DERMATITIS, URTICARIA, HAY FEVER, GASTROINTESTINAL ALLERGY AND FOOD ALLERGY | EISAI CO., LTD. (JP) | 2001-12-25 | — | — | US | disclosed |
| JP-H11100373-A | NEW PHENOTHIAZINE DERIVATIVE AND ITS MEDICINE | EISAI CO LTD | 1999-04-13 | — | — | JP | disclosed |
| EP-0889037-A1 | NITROGENOUS TRICYCLIC COMPOUNDS AND DRUGS COMPRISING THE SAME | Eisai Co., Ltd. (JP) | 1999-01-07 | — | — | EP | disclosed |
| US-5240762-A | Mixed stacked charge transfer complex of donor and acceptor molecules | KABUSHIKI KAISHA TOSHIBA (JP) | 1993-08-31 | — | — | US | disclosed |
| EP-0478380-A1 | Organic thin film element | KABUSHIKI KAISHA TOSHIBA (JP) | 1992-04-01 | — | — | EP | disclosed |
| US-4375006-A | ALKYL GALLATE AND PHENOTHIAZINE, ALKYLPHENOTHIAZINE OR 4-TERT-BUTYLCATECHOL | ETHYL CORPORATION (US) | 1983-02-22 | — | — | US | disclosed |
| US-4343956-A | GALLATE ESTER AND TETRAMETHYL-P-PHENYLENEDIAMINE | ETHYL CORPORATION (US) | 1982-08-10 | — | — | US | disclosed |
| US-3945941-A | POLYETHYLENE OR POLYPROPYLENE STORAGETANK LINERS | OXIRANE CORPORATION (US) | 1976-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020103189-A1 | Nitrogen-containing tricyclic compounds and drugs containing the same | HRH2, HRH1, HRH4 | NOX1 95/4885GAA 2917/4885MAPT 1551/4885 |
| US-20120302556-A1 | Antiviral Compounds | HAVCR2, MAVS, EIF2AK2 | NOX1 2733/4885GAA 191/4885MAPT 1569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.